273 related articles for article (PubMed ID: 36058935)
1. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
[TBL] [Abstract][Full Text] [Related]
2. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
3. Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.
Su W; Choy KT; Gu H; Sia SF; Cheng KM; Nizami SIN; Krishnan P; Ng YM; Chang LDJ; Liu Y; Cheng SMS; Peiris M; Poon LLM; Nicholls JM; Yen HL
J Infect Dis; 2023 May; 227(10):1143-1152. PubMed ID: 35776136
[TBL] [Abstract][Full Text] [Related]
4. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
Bauer L; van Riel D
mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750
[TBL] [Abstract][Full Text] [Related]
5. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
[TBL] [Abstract][Full Text] [Related]
6. The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
Martins M; Nooruzzaman M; Cunningham JL; Ye C; Caserta LC; Jackson N; Martinez-Sobrido L; Fang Y; Diel DG
J Virol; 2024 Mar; 98(3):e0190223. PubMed ID: 38421180
[TBL] [Abstract][Full Text] [Related]
7. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
8. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
[TBL] [Abstract][Full Text] [Related]
10. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
[TBL] [Abstract][Full Text] [Related]
12. The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures.
Kase Y; Sonn I; Goto M; Murakami R; Sato T; Okano H
Exp Neurol; 2023 May; 363():114379. PubMed ID: 36914084
[TBL] [Abstract][Full Text] [Related]
13. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
[TBL] [Abstract][Full Text] [Related]
15. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.
Khan M; Clijsters M; Choi S; Backaert W; Claerhout M; Couvreur F; Van Breda L; Bourgeois F; Speleman K; Klein S; Van Laethem J; Verstappen G; Dereli AS; Yoo SJ; Zhou H; Dan Do TN; Jochmans D; Laenen L; Debaveye Y; De Munter P; Gunst J; Jorissen M; Lagrou K; Meersseman P; Neyts J; Thal DR; Topsakal V; Vandenbriele C; Wauters J; Mombaerts P; Van Gerven L
Neuron; 2022 Dec; 110(23):3919-3935.e6. PubMed ID: 36446381
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
Uraki R; Kiso M; Imai M; Yamayoshi S; Ito M; Fujisaki S; Takashita E; Ujie M; Furusawa Y; Yasuhara A; Iwatsuki-Horimoto K; Sakai-Tagawa Y; Watanabe S; Hasegawa H; Kawaoka Y
Nat Microbiol; 2022 Aug; 7(8):1252-1258. PubMed ID: 35705860
[TBL] [Abstract][Full Text] [Related]
17. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
McMahan K; Giffin V; Tostanoski LH; Chung B; Siamatu M; Suthar MS; Halfmann P; Kawaoka Y; Piedra-Mora C; Jain N; Ducat S; Kar S; Andersen H; Lewis MG; Martinot AJ; Barouch DH
Med; 2022 Apr; 3(4):262-268.e4. PubMed ID: 35313451
[TBL] [Abstract][Full Text] [Related]
18. Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta.
Wang E; Yang QJ; Xu XX; Zou QC; Long Y; Ma G; Deng ZH; Zhao JB; Li MH; Zeng J
J Med Virol; 2024 Jan; 96(1):e29357. PubMed ID: 38235532
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters.
Abdelnabi R; Lassaunière R; Maes P; Weynand B; Neyts J
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257822
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of olfactory dysfunction in D614G, alpha, delta and omicron waves: a psychophysical case-control study.
Vaira LA; Lechien JR; Deiana G; Salzano G; Maglitto F; Piombino P; Mazzatenta A; Boscolo-Rizzo P; Hopkins C; De Riu G
Rhinology; 2023 Feb; 61(1):32-38. PubMed ID: 36272169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
